Please join me at European Cancer Organisation “Community 365 Roundtable on Time to Treatment” that starts in just under an hour. The registration is still open (see link in the comments). Will be co-chairing the session on coordinating patient pathways. And in my panel talk will highlight clinical burden of longer time-to-treatment through increased mortality; financial implications of later stage #cancer; and the psychosocial impact on patients. Will start the discussion on ways to improve time to treatment in oncology through: •      #EarlyDetection and #CancerScreening (including personalized risk assessment; predictive detection; public awareness campaigns; implementation of liquid biopsy testing) •      Streamlined referral processes (primary care integration; electronic referrals) •      Efficient diagnostic pathways (like rapid diagnostic centers; standardized protocols) •      Improved access to specialists (using telemedicine; effective multidisciplinary decision making) •      Optimized treatment planning (efficient tumor boards management; greater care coordination) •      Patient support and education (through clear and accessible information; supportive services incl. psychological and logistical assistance; financial counseling) •      Policy and system-level interventions (via healthcare policies; resource allocation; and improved guidelines) •      Technology and innovation Looking forward to it! #GEHealthCare

Today, I am celebrating the announcement of Memora's multi-year partnership with Intermountain Health. Together, we will initially focus on cancer care with plans to extend across additional areas over the next several years, enabling Intermountain to scale personalized, high-quality care, while streamlining workflows for care teams. I know the challenges patients face in trying to navigate the cancer care journey, as I have seen this firsthand both as a physician as well as within my own family. That's why Memora Health has developed proactive cancer support programs powered by AI. Rather than sending patients home from a doctor’s visit with only paperwork, Memora’s conversational AI can instantly address patient questions about their treatment, medications, and side effects. When necessary, Memora’s platform can identify complex issues and connect them to their doctor or clinical care team for more support. In this way, the technology empowers health systems to scale personalized, high-quality care while also minimizing time spent by providers on routine administrative tasks. I hope you follow along as we continue our journey to make healthcare more accessible, actionable, and always-on.

Dogs Without Borders is a unique project that’s currently helping potential breast cancer patients access diagnostics in remote areas. (It’s almost an entire health ecosystem in its own right.) The work was named as 2023’s second most awarded health campaign in the world by The Drum. Whilst we are so proud of all the teams who made it happen, we also want to take a moment to reflect on the wider implications of what we do to help drive forward survival rates to one of our biggest global health challenges – cancer.

 The project shows how communications can help move cancer care forward by looking at problems in new and different ways and working collaboratively to develop solutions that put the patient at the center. It’s an advert for the power of ideas, showing how the combination of innovative thinking, tech and creative collaboration can close equity gaps in health. Thanks to a great partnership with SFBO, we were able to develop something that’s truly helping people access cancer care, and in the process, giving abandoned dogs – previously left to die – a home.

If you’ve not seen the video yet, check it out. #VMLHealth #HealthcareMarketing #Healthcare #PharmaMarketing #Pharma

Local context need to be applied for the success of local solutions, but having ready products that can be adapted to local needs and local ongoing projects, will leap frog the solutions! Derrick Z CHAN #GreaterPetalingcitycancerchallenge

📣 Calling All Companies: Partner with Us to Drive Change in Cancer Research At the MMRF, our work is guided by three core pillars: accelerate the development of novel therapies, drive optimal and more personalized treatment approaches, and empower patients and the myeloma community. Central to our mission is a commitment to advancing health equity so that all myeloma patients can benefit from the scientific and clinical advances we pursue. 🤝 Why Partner with the MMRF? Community-Driven Events: Join us for our impactful events that raise awareness and funds for groundbreaking research. Our events are not just gatherings; they are platforms for change, bringing together communities, leaders, advocates, and patients. Health Equity: Partner with us to address disparities in cancer care. By supporting our Diversity, Equity, and Inclusion programs, you can be a catalyst for change, ensuring equitable access to treatments and clinical trials for all. Educational Resources: Collaborate with us to provide comprehensive educational programs that empower patients, caregivers, and healthcare providers. Our resources include multimedia content, podcasts, webinars, and publications that address various stages of myeloma, from diagnosis to treatment, and beyond. ⭐ Let's Make a Difference Together ⭐ 📩 Connect with me today to learn how your organization can play a pivotal role in research that carries with it the potential to discover more effective treatments and save more lives: abrahamt@themmrf.org. #MultipleMyeloma #CancerResearch #HealthEquity #CorporatePartnerships

Mon Health is at the forefront of healthcare innovation using predictive analytics to identify individuals at risk for lung cancer and deploying targeted communications encouraging patients to get screened. Discover how Mon Health System is leading the charge in proactive healthcare and shaping the future of patient-centric care: bit.ly/3rr9iMt

Transforming risk prediction: @Huron's innovative approach goes beyond the norm, utilizing a proprietary dataset and the ability to ingest EHR data and external health determinants.   Imagine the power to pinpoint high-risk patients early on, offering the chance for timely intervention.   Would you want the ability to unlock this crucial health information?  

Inadequate clinical communication models for evolving cancer information are increasingly problematic and directly impact many individuals within the healthcare ecosystem. This issue necessitates the need to address the rising number of survivors requiring personalized complex care, the growing recognition of the  importance of involving care partners in decision-making, and the increasing time demands on a shrinking workforce to coordinate care and effectively provide needed knowledge.  Shared decision-making recognizes that healthcare professionals are experts in medical evidence, while patients are experts in their own values. This model relies on the involvement of both the patient and their care partner in decision making. It requires patients to access, assess, and reflect on information. Providing personalized, curated information helps patients synthesize evolving cancer information, enhancing engagement and decision-making capacity. Wouldn't it be great if there was an interactive communication journey map for the delivery of precision curated content for oncology patients, caregivers and care teams and new innovative tools that can assist with understanding evolving information when making cancer related decisions. And wouldn't it be great if this was co-developed with under resourced communities to provide equitable care? #supportivecare #survivorship #communication

Employers are facing rising cancer costs and increasing employee needs as they plan benefit offerings for 2024. Poor screening rates, rising drug costs, and varying quality of care plague even the most thoughtful benefit plans. What are employers doing now to meet these challenges? What is the best path forward? The answer may lie in the Member’s experience itself. Join Transcarent leaders and Prachi Nagda MD from Mercer for our upcoming webinar “Mind the Member: Fixing the Fragmented Experiences in Cancer Care.” They'll have a thoughtful discussion on the future of cancer care and how we can put the Member at the center of benefit plan design. https://bit.ly/3RpZxIw

Join us as Louis Culot, General Manager of CancerLinQ at ConcertAI, takes us on a journey through the groundbreaking ways CancerLinQ is transforming cancer care. By harnessing the power of data, CancerLinQ is making it easier for healthcare providers to navigate the complexities of cancer care. Deployed across the U.S. in academic centers, community clinics, and large health systems, this innovative platform is enhancing treatment decisions and improving patient outcomes. With tools like the SmartLinQ portal, integrated seamlessly with electronic medical records, doctors receive crucial alerts right when they need them most! This means more informed decisions at critical points in a patient's treatment journey. Technologies like RxLink and TriaLinQ empower healthcare professionals to identify patients who are eligible for new therapies and clinical trials—addressing a pressing issue: only 7% of patients currently access these vital opportunities. By analyzing disparities in cancer care, CancerLinQ is committed to driving concordant care, ensuring that every patient receives the best possible treatment tailored to their unique needs. Let's support a future where cancer care is not just a battle, but a journey informed by data and compassion! Learn more about CancerLinQ: https://hubs.ly/Q02Md1b80 #CancerCare #DataDriven #HealthInnovation #ClinicalTrials #PatientOutcomes #ConcertAI #FightCancer #HealthcareTransformation